Company Information

Company NamePhase Holographic Imaging PHI AB
Company Idea

PHI leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.

CEO  Peter Egelberg
Chairman of the Board  Klas Cramborn
Board  Klas Cramborn
Bengt Falk
Leland Foster
Mats Lundwall
Jan Richardsson
Articles Of Association  Bolagsordning 2014-10-06.pdf
Registration Number  556542-7811
Visiting Address  Scheelevägen 22
Zip Code  223 63
City  LUND
Home Page  
e-Mail Address  
Telephone  046-46 38 60 80
Company Presentation (video)  Bolagspresentation

Instrument Information

Stock Name  Phase Holographic
Ticker Name  PHI
AktieTorget's ID  XSAT01001235
ISIN Number  SE0005504636
OrderBookID  99348
Number of shares  11,642,705
Par value  0.2 SEK
First Traded  1/20/2014
Instrument Type  Share

Major Share Holders (according to Euroclear) - per 6/30/2017 **

NameCapital %Votes %
Avanza Pension8.698.69 
Neural AB6.396.39 
Singapore Branch-, Dcs Client A Deutsch Bank AG3.353.35 
Peter Egelberg3.323.32 
Nordnet Pensionsförsäkring3.053.05 

** uppdateras kvartalsvis, ca 5 veckor efter kvartalets slut

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se